AUNA
AunaAUNA
AUNA
About: Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru and Healthcare services in Peru, Columbia and Mexico. Key revenue is generated from Peru.
Employees: 14,842
0
Funds holding %
of 7,457 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
8% more capital invested
Capital invested by funds: $29.4M [Q4 2024] → $31.6M (+$2.21M) [Q1 2025]
0.53% more ownership
Funds ownership: 14.26% [Q4 2024] → 14.8% (+0.53%) [Q1 2025]
5% less funds holding
Funds holding: 19 [Q4 2024] → 18 (-1) [Q1 2025]
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Research analyst outlook
We haven’t received any recent analyst ratings for AUNA.
Financial journalist opinion
Based on 3 articles about AUNA published over the past 30 days
Neutral
Zacks Investment Research
4 days ago
Auna S.A. (AUNA) Reports Next Week: What You Should Expect
Auna S.A. (AUNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neutral
Business Wire
1 week ago
Auna Announces Pricing of Additional 10.000% Senior Secured Notes Due 2029
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of its previously announced offering of an additional $62.1 million in aggregate principal amount of its 10.000% senior secured notes (the “Additional Notes”) in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”.
Neutral
Business Wire
1 week ago
Auna Announces Proposed Offering of Additional 10.000% Senior Secured Notes Due 2029
MONTERREY, Mexico--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced that it intends to offer additional 10.000% senior secured notes (the “Additional Notes”) in a private offering to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons in accordance with Re.
Neutral
Business Wire
1 month ago
Auna Announces the Filing of Its Form 20-F for the Fiscal Year 2024
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”) (NYSE: AUNA), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2024, with the Securities and Exchange Commission (the “SEC”) on April 10, 2025. Auna's Annual Report on Form 20-F can be accessed by visiting either the SEC's website at www.sec.gov or the “Financial Info” section of the Company's Invest.
Positive
Seeking Alpha
1 month ago
Auna: Strong Q4, Execution In Mexico Will Be Key, Reiterating Buy
Auna achieved strong 2024 results with 11% revenue growth and 20% EBITDA growth, driven by successful operations in Peru and expansion efforts in Mexico. Mexico's market potential is significant, with strategic partnerships and a focus on oncologic plans, while Colombia faces regulatory challenges impacting profitability. The company is focused on deleveraging, aiming for a leverage ratio below 3X by 2025, driven by a projected 20% EBITDA growth.
Negative
Zacks Investment Research
1 month ago
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?
Here is how Auna S.A. (AUNA) and Coya Therapeutics, Inc. (COYA) have performed compared to their sector so far this year.
Neutral
Business Wire
2 months ago
Auna Announces 4Q24 and FY 2024 Financial Results
LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the fourth quarter ended December 31, 2024 (“fourth quarter 2024” or “4Q24”) and full year ended 2024 (“full-year 2024” or “FY24”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unles.
Neutral
Business Wire
2 months ago
Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey
MONTERREY, Mexico--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading oncolo.
Positive
Zacks Investment Research
2 months ago
Is Auna S.A. (AUNA) Stock Outpacing Its Medical Peers This Year?
Here is how Auna S.A. (AUNA) and BioMarin Pharmaceutical (BMRN) have performed compared to their sector so far this year.
Positive
Zacks Investment Research
3 months ago
Wall Street Analysts Predict a 39.33% Upside in Auna S.A. (AUNA): Here's What You Should Know
The mean of analysts' price targets for Auna S.A. (AUNA) points to a 39.3% upside in the stock.
Charts implemented using Lightweight Charts™